Emerald Health Therapeutics, Inc. (OTCMKTS:EMTHTF) has been granted a cultivation license by Health Canada for its organic cultivation facility in Metro Vancouver, BC. The facility is customized for the production of high-quality organic cannabis from two 78,000 sq. ft. greenhouses as well as 500,000 sq. ft. of outdoor growing with the possibility of an additional 12 acres.
Emerald expects annual production in excess of 30,000 kg
The license allows Emerald to initially carry out cultivation in a 15,000 sq. ft. greenhouse space. The site was specifically designed for organic cannabis growing with the aim of exceeding annual production of 30,000 kg if there will be licensing for the whole outdoor and indoor production area.
Emerald CEO and Chairman Dr. Avtar Dhillon stated that organic products are appealing to most consumers as well as cannabis users and the company is looking forward to serving both recreational and medical users of Emerald’s premium cannabis products. The CEO indicated that the company designed the state-of-the-art facility to use natural light and it also has the latest climate control systems that are energy efficient. He also added that the company is applying select genetics from its large genetic library that is perfectly suited for indoor and outdoor cultivation.
Emerald using proprietary genetics to produce premium organic cannabis products
Through a combination of improved infrastructural designs, efficient operations as well as prudently picked genetics the company is aiming at the production of clearly differentiated organic products that are appealing to consumers. Emerald expects the outdoor cultivation to have a low-cost base compared to greenhouse production which will contribute considerably to profit margins.
The construction of the first greenhouse has already been finalized with completion of the second expected in Q4. Equally the first 12 acres of outdoor space is ready for planting. Emerald is working currently on the necessary municipal approvals for them to begin production at the Metro Vancouver facility.
The company has also indicated that Punit Dhillon has been granted a Health Canada security clearance and reappointed to Emerald’s Board of Directors.
Tinley Beverage Company Inc (OTCMKTS:TNYBF) Ships First Batch Of Third Party Products From Its Long Beach, California Based Facility
Tinley Beverage Company Inc (OTCMKTS:TNYBF) shipped its first batch of third-party products manufactured at its Long Beach, California-based facility. Also, a leading cannabis and cannabidiol beverage brand – Good Stuff Beverage Co will move its natural tonics production to Tinley’s facility.
Good Stuff’s classic flavors comprise a new and terpene-infused formula. It will demonstrate the launch of high dose and strain-specific tonic.
Its product line comprises the Original Honey Lemonade, Sativa Energy, and Indica Calm. Consumers can use a resealable bottle cap to take an exact dose and sip easily.
President (West Coast USA) of Tinley, Rick Gillis, said any company usually faces challenges in manufacturing fruit-infused drinks while ensuring shelf stability and quality. Its team of food process and quality experts and specialized production equipment will play a vital role in delivering the required stability and consistency for this fruit-derived brand.
The cannabis community in California has well-accepted the products of Good Stuff. Therefore, they will love to receive enhanced formula-based products from Good Stuff.
Co-founder of Good Stuff, Daniel Grim, said Good Stuff Beverages is an excellent Tinley value proposition. The custom-built equipment and talented team of Tinley will help Good Stuff in its scalability.
Distribution boost through retail in Alberta
Tinley said its product distribution continues to improve through enhanced retail stores in Alberta. It also receives requests from provincial buyers for cannabis products.
According to a communiqué from local agents, the company received commitments or listings for its ready-to-drink cocktails and Beckett’s non-alcoholic spirits at 30 retailers across Alberta. The company is excited to receive reorders within one week of the initial listings.
Tinley raised a capital of $850,000 through a non-brokered private placement of 2.125 million units at $0.40.
Manufactures zero-calorie sparkling drinks
Tinley is pleased to announce that its Long Beach facility will manufacture Calexo’s four preservative-free juice beverages and zero-calorie sparkling drinks.
Innovative cannabis blended sparkling waters, which are branded as Watercolors, will be blended with 5mg THC and natural botanicals in a 12oz bottle. It is developed for those looking to replace alcohol.
Pao Group Inc. (OTCMKTS:PAOG) Expanding Its Neutraceutical Revenue Streams
Pao Group Inc. (OTCMKTS:PAOG) has announced that it expects revenue expansion this year from CBD neutraceuticals. The company published an online and multimedia presentation showing its CBD nutraceutical development expansion plans. Most importantly, the presentation includes its strategy engagements with Puration Inc. (OTCMKTS:PURA), Alkme Holdings Inc. (OTCMKTS:ALKM), and North American Cannabis Holdings Inc. (OTCMKTS:USMJ).
Pao Group acquired RespRx in 2020
Last year, the company completed the acquisition of RespRx, a cannabis medication currently under development for the treatment of Chronic Obstructive Pulmonary Disorder derived through a patented marijuana extraction method. According to WHO, around 65 million globally have moderate to severe COPD, with around three million deaths reported each year. COPD treatment market is estimated to be around $5 billion in the US and $11 billion globally.
Notably, GW Pharmaceuticals has set the base for cannabis treatment and recently was valued at $7.2 billion. The patented extraction method inventor Frederic Ferri said that doctors researching their feedback have given feedback regarding the feedback’s superiority compared to those of GW Pharmaceuticals.
Pao Group recently entered an engagement with Veristat Inc. to assist in advancing its novel CBD extract for COPD treatment towards an IND with the US FDA. The company recognizes and acknowledges that pharmaceutical development will be a capital intensive and long-term undertaking. As a result, Pao Group is pursuing complementary business initiatives that can generate revenue in the near term and contribute to funding the RespRx development in the long term.
Pao Group expanding nutraceutical development
Besides efforts to develop COPD treatment, the company also announced that it has engaged Puerto Rico Consortium for Clinical Investigation to help it develop novel CBD extract into nutraceutical products for the care of individuals experiencing issues related to COPD. Pao Group management is confident that CBD extraction knowledge base and experience can help pursue the development of more neutraceuticals.
As a result, doing so will expand the company’s overall near-term revenue potential. The company expects revenue this year from neutraceuticals following the recent sales agreement with Puration. The company expects revenue of $50,000 each quarter.
Body and Mind Inc (OTCMKTS:BMMJ) Posts A Growth Of 300% YoY In Revenues In Q2 2021
Body and Mind Inc (OTCMKTS:BMMJ) reported a stellar growth of 300% YoY to $6.31 million in Q2 2021. Its profits also surged by a whopping 400% to $2.74 million.
Body and Mind’s subsidiary took full ownership of ShowGrow Long Beach dispensary in California on August 28, 2020, to consolidate revenues. ShowGrow allows purchase online besides offering curbside pickup.
In California, ShowGrow San Diego dispensary offers curbside pickup service besides delivery service and online ordering options.
The sale of Body and Mind branded products is commenced through all dispensaries across Nevada and Las Vegas. Following the receipt of approval for expanding the cultivation canopy, the company completed the cultivation space expansion. The company expects to improve the output by 20% from its new flowering rooms.
The company is pleased to receive a license from Nevada State. It will introduce a female-focused brand in alliance with its brand partner – Her Highness, in the market of Las Vegas.
Body and Mind’s ancillary took over the Clubhouse dispensary’s full stake in Ohio to consolidate revenues with effect from September 4, 2020. It renamed the dispensary as Body and Mind in September 2020. The company expects to complete the construction of the NMG manufacturing facility in Ohio in April 2021.
Body and Mind received the best dispensary award in Arkansas. The company commenced online ordering and delivery services in Arkansas.
CEO of Body and Mind, Michael Mills, said the company reported robust results and maintains a healthy balance sheet in Q2 2021. Michael further said the customers well accept its curbside pickup and delivery services for cannabis products.
Expects to improve revenues in 2021
Body and Mind’s team is working with state and local inspectors to receive final permits for its cultivation facility in Arkansas. It is also finalizing the construction of a manufacturing facility in Ohio. Both of these facilities expect to improve the revenues of Body and Mind in 2021.
Comprehensive Care Group, LLC and Body and Mind began cultivation operations at West Memphis on April 6, 2021, close to the Tennessee border.
Arkansas holds a total of 32 dispensaries. It expects to operate additional six dispensaries soon.